{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03802695",
            "orgStudyIdInfo": {
                "id": "OGFT001-001"
            },
            "organization": {
                "fullName": "Orca Biosystems, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies",
            "officialTitle": "A Phase 1 Dose Escalation and Expansion Study of Orca-Q, an Engineered Donor Graft Derived From Mobilized Peripheral Blood, in Recipients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies",
            "therapeuticArea": [
                "Rare Diseases",
                "Oncology and Hematology",
                "Other"
            ],
            "study": "a-phase-study-of-orca-q-in-recipients-undergoing-allogeneic-transplantation-for-hematologic-malignancies"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-04-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-01-10",
            "studyFirstSubmitQcDate": "2019-01-10",
            "studyFirstPostDateStruct": {
                "date": "2019-01-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Orca Biosystems, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will evaluate the safety, tolerability, and efficacy of engineered donor grafts (\"OrcaGraft\"/\"Orca-Q\") in participants undergoing myeloablative allogeneic hematopoietic cell transplant transplantation for hematologic malignancies."
        },
        "conditionsModule": {
            "conditions": [
                "Acute Myeloid Leukemia",
                "Acute Lymphoblastic Leukemia",
                "Myelodysplastic Syndromes",
                "Mixed Phenotype Acute Leukemia",
                "Myelofibrosis",
                "Chronic Myeloid Leukemia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 186,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm A",
                    "type": "EXPERIMENTAL",
                    "description": "Recipients with HLA-identical or 1-allele mismatched (7/8 alleles) related or unrelated donor; with single-agent GVHD prophylaxis given",
                    "interventionNames": [
                        "Biological: OrcaGraft (Orca-Q)"
                    ]
                },
                {
                    "label": "Arm B",
                    "type": "EXPERIMENTAL",
                    "description": "Recipients with haploidentical-related donors; with single-agent GVHD prophylaxis given",
                    "interventionNames": [
                        "Biological: OrcaGraft (Orca-Q)"
                    ]
                },
                {
                    "label": "Arm C",
                    "type": "EXPERIMENTAL",
                    "description": "Recipients with an HLA-identical related or unrelated donor; no GVHD prophylaxis given",
                    "interventionNames": [
                        "Biological: OrcaGraft (Orca-Q)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "OrcaGraft (Orca-Q)",
                    "description": "engineered donor allograft",
                    "armGroupLabels": [
                        "Arm A",
                        "Arm B",
                        "Arm C"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Dose Limiting Toxicities",
                    "description": "Safety and tolerability of Orca-Q (formerly OrcaGraft) in adults undergoing myeloablative allogeneic hematopoietic cell transplantation (MA-alloHCT) will be evaluated by identification of the following dose limiting toxicities: Grade \u2265 3 infusion-related reaction or cytokine release syndrome, Grade \u2265 3 acute GVHD, Any Grade \u2265 3 treatment-related non-hematologic event not clearly related to the underlying malignancy, intercurrent infection, the HCT conditioning regimen, or other pre-existing medical condition, and by instance of primary graft failure, defined as being alive without recovery of neutrophils during the evaluation period",
                    "timeFrame": "28 Days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Primary Graft failure through Day +28 (dose expansion)",
                    "description": "Primary graft failure in the dose expansion phase, defined as being alive without recovery of neutrophils during the evaluation period",
                    "timeFrame": "28 Days after administration of Orca-Q/OrcaGraft"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Neutrophil Engraftment through Day +28",
                    "description": "Neutrophil engraftment defined as an absolute neutrophil count of \\>/=500/mm3 for 3 consecutive days",
                    "timeFrame": "28 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Platelet engraftment through Day +50",
                    "description": "Platelet engraftment is defined as achieving a platelet count \\> 20,000/mm3 for 3 consecutive days without platelet transfusion in the preceding 7 days, by Day +50",
                    "timeFrame": "50 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Secondary graft failure through Day +100",
                    "description": "Secondary graft failure is defined as neutrophil engraftment followed by subsequent decline in absolute neutrophil counts \\< 500 cells/\u03bcL, unresponsive to growth factor therapy, by Day +100",
                    "timeFrame": "100 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Treatment-emergent adverse events (TEAEs) through the safety reporting period",
                    "description": "TEAEs categorized by System Organ Lass and graded according to the CTCAE v5.0",
                    "timeFrame": "100 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Acute GVHD through Day +100",
                    "description": "Acute GVHD will be staged and graded per Mount Sinai Acute GvHD International Consortium (MAGIC) Standardization criteria",
                    "timeFrame": "100 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Steroid-refractory acute GVHD through Day +100",
                    "description": "Steroid-refractory acute GVHD will be defined as per the EBMT-NIH-CIBMTR Task Force position statement",
                    "timeFrame": "100 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Chronic GVHD through Day +365",
                    "description": "Chronic GVHD will be diagnosed per 2014 International NIH Chronic GVHD Diagnosis and Staging Consensus Working Group criteria",
                    "timeFrame": "365 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Post-Transplant Lymphoproliferative Disorder (PTLD) through Day +365",
                    "description": "PTLD is defined as a biopsy consistent with the 2017 World Health Organization (WHO) classification of PTLD",
                    "timeFrame": "365 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Incidence of non-relapse mortality (NRM) through Day +365",
                    "description": "NRM is defined as death without evidence of disease recurrence",
                    "timeFrame": "365 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Incidence of disease relapse through Day +365",
                    "description": "Recurrence of primary disease for transplant",
                    "timeFrame": "365 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "GVHD-free and relapse-free survival (GRFS) through Day +365",
                    "description": "Survival free from GVHD and relapse",
                    "timeFrame": "365 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Disease-free survival (DFS) through Day +365",
                    "description": "Disease-free survival is the time from date of transplant to death or relapse, whichever comes first.",
                    "timeFrame": "365 days after administration of Orca-Q/OrcaGraft"
                },
                {
                    "measure": "Overall survival through Day +365",
                    "description": "OS is defined as the time from the date of transplant to the date of death from any cause or, for surviving patients, to the date of last follow-up.",
                    "timeFrame": "365 days after administration of Orca-Q/OrcaGraft"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n1. Age \u2265 18 and \u2264 65 years at the time of enrollment\n2. Diagnosed acute myeloid, lymphoid or mixed phenotype leukemia, or high or very high risk myelodysplasic syndrome (MDS), myelofibrosis, or chronic myeloid leukemia\n3. Planned to undergo myeloablative allogeneic hematopoietic stem cell transplant (HCT)\n4. Matched to a 8/8 or 7/8 related or unrelated donor, or to a related haploidentical donor\n5. Estimated glomerular filtration rate (eGFR) \\> 50 mL/minute\n6. Cardiac ejection fraction at rest \u2265 45% or shortening fraction of \u2265 27% by echocardiogram or radionuclide scan (MUGA)\n7. Diffusing capacity of the lung for carbon monoxide (DLCO) (adjusted for hemoglobin) \u2265 50%\n8. Total bilirubin \\< 1.5 times upper limit of normal (ULN) (\\< 3 times if attributed to Gilbert's syndrome) and ALT/AST \\< 3 times ULN\n\nKey Exclusion Criteria:\n\n1. Prior allogeneic HCT\n2. Currently receiving corticosteroids or other immunosuppressive therapy. Topical corticosteroids or oral systemic corticosteroid doses less than or equal to 10 mg/day are allowed.\n3. Planned donor lymphocyte infusion (DLI)\n4. Positive anti-donor HLA antibodies against a mismatched allele in the selected donor\n5. Karnofsky performance score \\< 70% (Appendix 12.7)\n6. Hematopoietic cell transplantation-specific Comorbidity Index (HCT-CI) \\> 4 (Appendix 12.8)\n7. Uncontrolled bacterial, viral or fungal infections (currently taking antimicrobial therapy and with progression or no clinical improvement) at time of enrollment\n8. Seropositive for HIV-1 or -2, HTLV-1 or -2\n9. Any uncontrolled autoimmune disease requiring active immunosuppressive treatment\n10. Concurrent malignancies or active disease within 1 year, except non-melanoma skin cancers that have been curatively resected\n11. History of idiopathic or secondary myelofibrosis\n12. Women who are pregnant or breastfeeding",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "James S McClellan, MD, PhD",
                    "role": "CONTACT",
                    "phone": "1-530-414-9743",
                    "email": "info@orcabiosystems.com"
                },
                {
                    "name": "Tamara Zharkevich, MD PhD",
                    "role": "CONTACT",
                    "phone": "1-530-414-9743",
                    "email": "info@orcabiosystems.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "James S McClellan, MD, PhD",
                    "affiliation": "Orca Biosystems, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amandeep Salhotra, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "UC Davis",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mehrdad Abedi, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "Stanford Health Care",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robert Lowsky, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "Emory University",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edmund Waller, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "The University of Kansas Hospital",
                    "status": "WITHDRAWN",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "Ohio State University",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ayman Saad, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77054",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samer Srour, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Froedtert Memorial Lutheran Hospital",
                    "status": "WITHDRAWN",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53226",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000054198",
                    "term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
                },
                {
                    "id": "D000019337",
                    "term": "Hematologic Neoplasms"
                },
                {
                    "id": "D000015464",
                    "term": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
                },
                {
                    "id": "D000009190",
                    "term": "Myelodysplastic Syndromes"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000009196",
                    "term": "Myeloproliferative Disorders"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M21314",
                    "name": "Hematologic Neoplasms",
                    "asFound": "Hematologic Malignancies",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27585",
                    "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "relevance": "LOW"
                },
                {
                    "id": "M18123",
                    "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
                    "asFound": "Chronic Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28312",
                    "name": "Primary Myelofibrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18127",
                    "name": "Leukemia, Myeloid, Acute",
                    "relevance": "LOW"
                },
                {
                    "id": "M14164",
                    "name": "Preleukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M12145",
                    "name": "Myelodysplastic Syndromes",
                    "asFound": "Myelodysplastic Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12149",
                    "name": "Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T175",
                    "name": "Acute Lymphoblastic Leukemia",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3533",
                    "name": "Lymphoblastic Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1309",
                    "name": "Chronic Myeloid Leukemia",
                    "asFound": "Chronic Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4705",
                    "name": "Primary Myelofibrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T182",
                    "name": "Acute Myeloid Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T188",
                    "name": "Acute Non Lymphoblastic Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T3993",
                    "name": "Myelodysplastic Syndromes",
                    "asFound": "Myelodysplastic Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T174",
                    "name": "Acute Leukemia of Ambiguous Lineage",
                    "asFound": "Mixed Phenotype Acute Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T1311",
                    "name": "Chronic Myeloproliferative Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}